The TTS Global Initiative

The TTS Global Initiative is the leading international platform for early stage life sciences tech transfer, licensing, partnering, and investment.  It includes an interlinked global series of exclusive summits, the proprietary TTS Innovation Bank for the submission and dissemination of technology offerings, and counts amongst its members the leading stakeholders in the industry worldwide.

The TTS Global Initiative is an important community for entrepreneurial researchers & innovators; university, institute, clinic and hospital Tech Transfer Offices; early stage start-ups; biotech and pharmaceutical corporations, and investors alike. Inaugurated in 2007, the initiative enables all stakeholders in the early stage sector to successfully network, collaborate and form partnerships that can help drive forward innovative technologies to the commercial markets.

The TTS Global Initiative 2013 includes:

  • TTS Europe, at the Wellcome Trust, London, United Kingdom, 1 - 2 July, 2013
  • TTS North America, Genentech Hall, at University of California, San Francisco (Mission Bay Campus), California, USA, 29-30 July, 2013
  • TTS Australia, at the Walter and Eliza Hall Institute (WEHI) of Medical Research, in Melbourne, Australia, 3-4 September, 2013
  • TTS Asia, Singapore, 5 - 6 December, 2013

Please check back soon for the full websites and details for each of these summits.

To become a part of the TTS Global Initiative, win a free VIP pass for the TTS of your choice, stay informed on the TTS Global Initiative, and receive key updates, discounts, and special offers: join here

Recent Blog Posts

December 7, 2013